Media-OutReach Newswire Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases
Media-OutReach Newswire Prudential study: 1 in 2 say that digital technology is most important in getting ready for 100
Media-OutReach Newswire Prudential launches mobile app to provide SME employees with easy access to medical and company benefits
Media-OutReach Newswire Prudential and Nervotec enter exclusive partnership to bring better health to communities in Asia and Africa
Society Booster shot against diphtheria, pertussis, tetanus, and polio at 4-6 years imperative: seminar
Five-year visa exemption considered for global talents, including top scientists, executives, artists 2.